DIACEUTICS
 
Notifications
Clear all

DXRX - DIACEUTICS - Share Chat

Price: Market Cap.: (Ā£m)

Diaceutics plc (AIM: DXR) is a UK-based data analytics and software company operating within the precision medicine landscape. Its core business focuses on improving the commercialisation of new precision medicines by helping pharmaceutical companies understand and optimise diagnostic testing pathways.

Diaceutics leverages its proprietary global data lake of diagnostic test results to provide valuable insights into testing behaviours, patient identification, and test adoption rates. This enables pharma clients to refine their strategies, ensure the right patients are identified and tested, and ultimately improve the uptake of their targeted therapies. The company aims to accelerate drug launches and enhance patient access to precision medicines by addressing critical diagnostic challenges.

Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

Chat about DIACEUTICS


1 Reply
Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

Diaceutics (DRGX) recently reported strong full-year results, highlighting significant revenue growth in the precision medicine sector. With their unique data-driven approach, do you see them as a compelling long-term play? What are your thoughts on their market position and future prospects in this rapidly evolving field?


Reply

Scroll to Top